Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

1. Cell wall-inhibiting antibiotics resistance in Streptococcus pneumoniae causing invasive diseases: a global systematic review and meta-analysis in pediatric populations.Italian journal of pediatrics · 2025
   Pooled it
2. Glycopeptide resistance in gram-positive cocci: a review.Interdisciplinary perspectives on infectious diseases · 2012
   Article
3. In vitro activity of daptomycin against Staphylococci isolated from bacteremia and community-onset skin and soft tissue infections in France: data from two nationwide studies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2009
   Article
4. The rise and fall of bacterial clones: Streptococcus pneumoniae.Nature reviews. Microbiology · 2008
   Review
5. Nationwide study of the prevalence, characteristics, and molecular epidemiology of extended-spectrum-beta-lactamase-producing Enterobacteriaceae in France.Antimicrobial agents and chemotherapy · 2008
   Article
6. Clonal spread of mef-positive macrolide-resistant Streptococcus pneumoniae isolates causing invasive disease in adults in Germany.Antimicrobial agents and chemotherapy · 2007
   Article
7. Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.Drugs · 2007
   Review
8. Vancomycin-tolerant Streptococcus pneumoniae in Korea.Journal of clinical microbiology · 2006
   Article
9. Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.Antimicrobial agents and chemotherapy · 2006
   Article
10. Antimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.Antimicrobial agents and chemotherapy · 2006
    Article
11. New real-time PCR assay using locked nucleic acid probes to assess prevalence of ParC mutations in fluoroquinolone-susceptible Streptococcus pneumoniae isolates from France.Antimicrobial agents and chemotherapy · 2006
    Article
12. Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002.Antimicrobial agents and chemotherapy · 2005
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

7 authors at 4 institutions in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as